{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:06:11Z","timestamp":1791644771197,"version":"4.3.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/icl.0b013e31822563be","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T04:22:33Z","timestamp":1311654153000},"page":"312-315","source":"Crossref","is-referenced-by-count":42,"title":["Effects of Topical Cyclosporine A Plus Artificial Tears Versus Artificial Tears Treatment on Conjunctival Goblet Cell Density in Dysfunctional Tear Syndrome"],"prefix":"10.1097","volume":"37","author":[{"given":"Elvan","family":"Demiryay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Yaylal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru Nevin","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Yldrm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.ico.0000214802.40313.fa","article-title":"Dysfunctional tear syndrome study group. Dysfunctional tear syndrome: A Delphi approach to treatment recommendations.","volume":"25","author":"Behrens","year":"2006","journal-title":"Cornea"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international dry eye workShop (2007) [Review].","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R3-8-20210128","first-page":"S88","article-title":"Management of dry eye disease [Review].","volume":"14","author":"Lemp","year":"2008","journal-title":"Am J Manag Care"},{"key":"R4-8-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine [Review].","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"R5-8-20210128","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":"Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","article-title":"Analysis of topical cyclosporine treatment of patients with dry eye syndrome.","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R7-8-20210128","first-page":"90","article-title":"Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.","volume":"42","author":"Brignole","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3341\/kjo.2007.21.4.189","article-title":"Short term effects of topical cyclosporine and viscoelastic on the ocular surface in patients with dry eye.","volume":"21","author":"Moon","year":"2007","journal-title":"Korean J Ophthalmol"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","article-title":"Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1542-0124(12)70085-X","article-title":"Management and therapy of dry eye disease: Report of the management and therapy subcommittee of the international dry eye workshop (2007).","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","article-title":"Grading of corneal and conjunctival staining in the context of other dry eye tests [Review].","volume":"22","author":"Bron","year":"2003","journal-title":"Cornea"},{"key":"R12-8-20210128","first-page":"2609","article-title":"Conjunctival T-cell subpopulations in Sjogrens and non-Sjogrens patients with dry eye.","volume":"43","author":"Stern","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ICO.0b013e31812f6782","article-title":"Management of ocular surface inflammation in Sjogren syndrome.","volume":"26","author":"Hyon","year":"2007","journal-title":"Cornea"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","article-title":"Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.","volume":"107","author":"Sall","year":"2000","journal-title":"Ophthalmology"},{"key":"R15-8-20210128","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1076\/ceyr.22.1.8.6977","article-title":"The conjunctival epithelium in dry eye subtypes: Effect of preserved and non-preserved topical treatments.","volume":"22","author":"Albietz","year":"2001","journal-title":"Curr Eye Res"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","article-title":"Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.icl.0000170599.57728.29","article-title":"An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye.","volume":"32","author":"Sall","year":"2006","journal-title":"Eye Contact Lens"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2008.08.015","article-title":"A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.","volume":"147","author":"Kim","year":"2009","journal-title":"Am J Ophthalmol"}],"container-title":["Eye & Contact Lens: Science & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00140068-201109000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:22:05Z","timestamp":1786047725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00140068-201109000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/icl.0b013e31822563be","relation":{},"ISSN":["1542-2321"],"issn-type":[{"value":"1542-2321","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}